authorization pfizer application emergency use everybody 16 years older advisory committee members voted 17 voted yes 1 abstained way unapproved vaccine available need undermining trial called expanded access expanded access enables clinician apply behalf patient fda drug vaccine not approved fda approves quickly fda companies joined pursue expanded access program emergency use built trial design undermining eua expanded access trial going intact allowing physicians administer vaccine candidate outside trial conditions comparable alternative distinguished bioethics group advocating expanded access recently vaccination high risk individuals clinical trials proceed concert doctors eligible high risk patients deciding benefits inoculation outweigh risks denying industry requests